AMPA Receptor Protein

AMPA Receptor Protein

Introduction

Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors (GluR1-4 or GRIA1-4) are the primary mediators of fast excitatory synaptic transmission in the mammalian central nervous system. [@hollmann1992] AMPA receptors have become recognized as fundamental to learning, memory, and information processing in the brain. The four subunits assemble in various combinations to form functional ion channels with distinct properties. [@dingledine1999]

AMPA receptors are essential for synaptic plasticity, including long-term potentiation (LTP) and long-term depression (LTD), the cellular correlates of learning and memory. Dysfunction of AMPA receptor trafficking and function has been strongly implicated in neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS). [@whitcomb2020][@zhou2019]

AMPA Receptor Protein

Introduction

Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors (GluR1-4 or GRIA1-4) are the primary mediators of fast excitatory synaptic transmission in the mammalian central nervous system. [@hollmann1992] AMPA receptors have become recognized as fundamental to learning, memory, and information processing in the brain. The four subunits assemble in various combinations to form functional ion channels with distinct properties. [@dingledine1999]

AMPA receptors are essential for synaptic plasticity, including long-term potentiation (LTP) and long-term depression (LTD), the cellular correlates of learning and memory. Dysfunction of AMPA receptor trafficking and function has been strongly implicated in neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS). [@whitcomb2020][@zhou2019]

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">AMPA Receptor</th></tr>
<tr><td><strong>Protein Name</strong></td><td>AMPA Receptor</td></tr>
<tr><td><strong>Gene Symbols</strong></td><td>GRIA1, GRIA2, GRIA3, GRIA4</td></tr>
<tr><td><strong>UniProt IDs</strong></td><td>P42262, P42263, P42264, P42265</td></tr>
<tr><td><strong>Subunit Composition</strong></td><td>Tetrameric</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Postsynaptic density, dendritic spines</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>AD, PD, ALS, Epilepsy, Schizophrenia</td></tr>
</table>
</div>

Structure

Subunit Architecture

AMPA receptor subunits have four domains:

• N-terminal domain: Subunit assembly, receptor tetramerization
• Ligand-binding domain (LBD): Binds glutamate, flip/flop variants
• Transmembrane domain: Four segments (M1-M4), pore formation
• C-terminal domain (CTD): Variable, determines interactions

Subunit Composition

| Subunit | Gene | Calcium Permeability | Key Properties |
|---------|------|---------------------|-----------------|
| GluR1 | GRIA1 | High | LTP-critical |
| GluR2 | GRIA2 | Low | Calcium-impermeable, edited |
| GluR3 | GRIA3 | High | Autism link |
| GluR4 | GRIA4 | High | Developmental |

Normal Physiological Functions

Fast Excitatory Synaptic Transmission

AMPA receptors mediate the majority of fast glutamatergic neurotransmission. When glutamate is released, it binds to AMPA receptors, triggering Na⁺ influx and rapid depolarization.

Synaptic Plasticity

• LTP: Activity-dependent strengthening, requires GluR1 insertion
• LTD: Activity-dependent weakening, requires GluR2 endocytosis
• Homeostatic plasticity: Global scaling of synaptic strength

Ion Permeability

• GluR2-containing: Na⁺-permeable, Ca²⁺-impermeable
• GluR2-lacking: Calcium-permeable, triggers intracellular signaling

Role in Neurodegenerative Diseases

Alzheimer's Disease

• Reduced hippocampal GluR1 and GluR2 expression [@whitcomb2020]
• Amyloid-beta oligomers impair trafficking
• Reduced surface expression contributes to synaptic dysfunction

Parkinson's Disease

• Altered striatal AMPA receptor composition
• GluR2 phosphorylation changes in levodopa-induced dyskinesias

Amyotrophic Lateral Sclerosis

• Excitotoxicity via calcium-permeable AMPA receptors
• Reduced GluR2 in motor neurons
• Riluzole partially acts through AMPA modulation

Epilepsy

• GRIA2/GRIA4 mutations cause epileptic encephalopathy
• Aberrant trafficking contributes to hyperexcitability

Therapeutic Strategies

• Ampakines (CX516): Positive allosteric modulators, cognitive enhancement
• Perampanel: FDA-approved anticonvulsant
• Gene therapy: AAV-mediated GRIA1/GRIA2 delivery

Key Publications

See Also

• [GRIA1 Gene](/genes/gria1)
• [GRIA2 Gene](/genes/gria2)
• [Glutamate Signaling](/mechanisms/glutamate-signaling)
• [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)

External Links

• [UniProt: GRIA1 (P42262)](https://www.uniprot.org/uniprot/P42262)
• [UniProt: GRIA2 (P42263)](https://www.uniprot.org/uniprot/P42263)
• [IUPHAR/BPS Guide: AMPA Receptors](https://www.guidetopharmacology.org/GRID.jsp)

References